课题基金 / 基金详情

Developing AMPK activator as therapeutics for treatment and management of Inflammatory Bowel Disease

Developing AMPK activator as therapeutics for treatment and management of Inflammatory Bowel Disease
开发 AMPK 激活剂作为治疗和管理炎症性肠病的疗法
批准号：
412781
负责人：
Banskota Suhrid
金额：
$6.56万
依托单位：
McMaster University
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-10-01 至 2021-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=412781&lang=en
关键词：
Ampk Activator Dss-Induced Colitis Elisa Inflammation Inflammatory Cytokines Myeloperoxidase Activity Raw Macrophage Western Blot

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammatory bowel disease (IBD), that is commonly classified into Ulcerative colitis and Crohn's disease is the condition of inflammation in the gastrointestinal tract. The incidence of the disease has shown a dramatic increase in the last decades in Can
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金